Touch Stone Publishers | Sector Intel Daily | Healthcare | Priority 9
The Signal
The post-subsidy ACA marketplace risk pool is running more profitable than the carriers that stayed in it priced for, and a second guidance raise in six weeks turns that from a quarter into a pattern. Oscar Health’s Form 8-K filed this morning ahead of its Investor Day moves full-year 2026 medical loss ratio guidance to 81.0 to 82.0 percent (from 81.5 to 82.5) and earnings from operations to $600 to $800 million (from $500 to $700 million), following the August 6 raise from an original 82.4 to 83.4 percent MLR. Centene, the largest marketplace carrier, filed its own Form 8-K overnight reaffirming adjusted EPS above $4.80 into the Deutsche Bank Healthcare Summit, a floor it lifted from $3.40 on July 28 on a marketplace pretax margin target of 4.5 to 5 percent.
Why It Matters
Consensus going into 2026 was that the expiration of the enhanced premium tax credits would shrink the marketplace and leave carriers holding a sicker residual pool: the healthy priced out, the sick paying whatever it took. The first half of that happened. Effectuated enrollment is tracking toward roughly 17.5 million by KFF’s estimate, from 22.3 million in 2025, and Centene’s marketplace membership fell to 3.49 million at June 30 from 5.86 million a year earlier. The second half did not. Carriers priced 2026 for morbidity deterioration larger than what arrived, and risk adjustment transfers for the 2025 and 2026 benefit years are flowing in their favor. Oscar’s first-half MLR of 75.0 percent against 83.0 percent a year earlier is the cleanest print of that.
The strategic consequence is that 2026 marketplace margin is a pricing artifact, not a franchise. The 2027 rate filings now sitting with state regulators (a median proposed increase near 15 percent across the 276 filings KFF has tallied) were built before either company told the market its 2026 pool was this clean.
Defensive Risk. HCA, Tenet, Community Health Systems and Universal Health Services are exposed because the members who left the marketplace did not land in other coverage. HCA told investors on its July 24 call that its lost exchange patients migrated to uninsured almost one for one, with marketplace admissions down 15 percent, uninsured volume up 15 percent, and roughly $400 million of second-quarter income given up to the shift. The mechanism is payer-mix conversion: exchange reimbursement turning into self-pay bad debt and deferred elective surgery; the same policy sending patients to the hospital uninsured is the one sending margin to the carriers. The window is the 2027 open enrollment beginning November 1, when a second year of double-digit rate increases on the surviving pool pushes the next tranche of marginal members into the same self-pay bucket. The responsible defense is to rebuild the 2027 budget assuming zero recapture of lost exchange volume, expand point-of-service financial screening and Medicaid presumptive-eligibility capture now, and bring the charity-care and bad-debt reserve discussion to the audit committee before third-quarter results, not after.
Offensive Advantage. Oscar, Centene’s Ambetter, Molina and the Elevance marketplace book are positioned because every carrier that priced 2026 for a sicker pool and received a healthier one is now carrying rate in excess of the risk it insures, and that surplus funds share-taking in 2027. The mechanism is that 2027 filings are already lodged at double-digit increases, so a carrier that trims its request in the final actuarial review, or holds price where competitors raise, buys the price-sensitive healthy members at the margin and lowers its own MLR further in the process. The window closes at rate finalization ahead of November 1 open enrollment, roughly six weeks from today. The responsible move is to file amended 2027 rates that concede two to four points of the proposed increase in the ten largest counties by membership, with the broker-commission and marketing spend to make the price visible before plan selection opens.
The Read
Over the next 30 to 90 days, expect a bifurcated Healthcare tape: managed-care names with marketplace exposure printing MLR beats through the third quarter, and for-profit hospital operators guiding bad debt and uncompensated care higher. Confirmation will appear in three places: Elevance and Molina third-quarter marketplace MLR in late October, the next CMS effectuated enrollment snapshot, and whether final 2027 rate approvals land below the filed medians as regulators push back on carriers now visibly over-earning. What would invalidate the read is a second-half MLR reversal at Oscar or Centene driven by the deferred-care rebound HCA is describing from the other side of the ledger (members who stopped using care in the first half returning in the second), which would show up as reserve strengthening in the third quarter rather than the $164 million of favorable prior-period development Oscar booked in the second.
Methodology
Silo 1 (SEC EDGAR) produced the signal. Oscar Health’s Form 8-K filed at 06:02 ET on September 16 (Item 7.01) scored Priority 9 as a forward guidance change that contradicts the adverse-selection consensus, corroborated within the silo by Centene’s Form 8-K filed at 18:54 ET on September 15. Per the selection rule, scanning stopped at the first Priority 9; Silo 2 (XLV flows) and Tier 2 were not scored. Other Silo 1 filings in the window (Summit Therapeutics’ HARMONi update at WCLC, Jazz closing Actio Biosciences, BioMarin discontinuing the VOXZOGO Noonan program, Teva’s ordinary-share NYSE listing) scored 8 or below as expected or incremental disclosures.
Board chairs and audit chairs: Take the Board Fiduciary AI Stress Test at touchstonepublishers.com/board-fiduciary-assessment